Access the full text.
Sign up today, get DeepDyve free for 14 days.
Paul Israel, E. Hippel (1990)
The Sources of InnovationTechnology and Culture, 31
(1992)
Exploring the limits of the technology S-curve, Parts I and XI
Bengt Holmstrom (1989)
AGENCY COSTS AND INNOVATIONJournal of Economic Behavior and Organization, 12
R. Amit, P. Schoemaker (1993)
Strategic assets and organizational rentSouthern Medical Journal, 14
I. Cockburn, R. Henderson (1994)
Racing To Invest? The Dynamics of Competition in Ethical Drug DiscoveryJournal of Economics and Management Strategy, 3
Richard Johnson, M. Hitt, R. Hoskisson (1993)
BOARD OF DIRECTOR INVOLVEMENT IN RESTRUCTURING: THE EFFECTS OF BOARD VERSUS MANAGERIAL CONTROLSStrategic Management Journal, 14
Amit Amit, Schoemaker Schoemaker (1993)
Strategic assets and organizational rentStrategic Management Journal, 14
B. Wernerfelt (1984)
A Resource-Based View of the FirmSouthern Medical Journal, 5
G. Hansen, B. Wernerfelt (1989)
DETERMINANTS OF FIRM PERFORMANCE: THE RELATIVE IMPORTANCE OF ECONOMIC AND ORGANIZATIONAL FACTORSSouthern Medical Journal, 10
B. Johns, W. Hogan (1961)
A THEORY OF THE GROWTH OF THE FIRMEconomic Record, 37
R. Henderson (1994)
The evolution of integrative capability: innovation in cardiovascular drug discoveryIndustrial and Corporate Change, 3
(1991)
Technological accumulation, growth options, and the sequence of entry
(1990)
The manufacturing sector master Measuring Competence? file: 1959-1987
Cockburn Cockburn, Griliches Griliches (1988)
Industry effects and appropriability measures in the stock market's valuation of R&D and patentsAmerican Economic Review Papers and Proceedings, 78
A. Vásquez (1959)
Leadership in administration. A sociological interpretationAmerican Political Science Review, 53
Peteraf Peteraf (1993)
The cornerstones of competitive advantage: A resource‐based viewStrategic Management Journal, 14
(1993)
Underinvestment and incompetence as responses to radical innovation: Evidence from the semiconductor photolithographic alignment equipment industry
B. Kogut, U. Zander (1992)
Knowledge of the Firm, Combinative Capabilities, and the Replication of TechnologyOrganization Science, 3
A. Gambardella (1992)
Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s *Research Policy, 21
(1980)
Conzpetitive Strategy
W. Mitchell (1992)
Are More Good Things Better, or Will Technical and Market Capabilities Conflict When a Firm Expands?Industrial and Corporate Change, 1
Lorraine Sheck, C. Cox, H. Davis, A. Trimble, W. Wardell, Ronald Hansen (1984)
Success rates in the United States drug development systemClinical Pharmacology & Therapeutics, 36
R. Nelson (1991)
Why do firms differ, and how does it matter?Southern Medical Journal, 12
R. Henderson, K. Clark (1990)
Architectural Innovation: The Reconfiguration of Existing Product Technologies and the Failure of
C. Gouriéroux, A. Monfort, A. Trognon (1984)
Pseudo Maximum Likelihood Methods: Applications to Poisson ModelsEconometrica, 52
Leonard‐Barton Leonard‐Barton (1992)
Core capabilities and core rigidities: A paradox in managing new product developmentStrategic Management Journal, 13
M. Koenig (1983)
A bibliometric analysis of pharmaceutical researchResearch Policy, 12
Wernerfelt Wernerfelt (1984)
A resource‐based view of the firmStrategic Management Journal, 5
Cynthia Montgomery, B. Wernerfelt (1988)
Diversification, Ricardian rents, and Tobin's qThe RAND Journal of Economics, 19
D. Minsker, James Macdonald, R. Robertson, D. Bokelman (1983)
Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.Teratology, 28 3
Ingemar Dierickx, Karel Cool (1989)
Asset stock accumulation and sustainability of competitive advantageManagement Science, 35
I. Cockburn, Z. Griliches (1987)
Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and PatentsInnovation Finance & Accounting eJournal
Margaret Peteraf (1993)
The cornerstones of competitive advantage: A resource‐based viewSouthern Medical Journal, 14
P. Hirsch (1975)
Organizational Effectiveness and the Institutional Environment.Administrative Science Quarterly, 20
T. Allen, Denis Lee, M. Tushman (1980)
R&D performance as a function of internal communication, project management, and the nature of the workIEEE Transactions on Engineering Management, EM-27
Peter Bamberger, R. Katz (1990)
Managing Professionals in Innovative Organizations: A Collection of Readings.Industrial and Labor Relations Review, 43
M. Hitt, R. Ireland (1985)
Corporate distinctive competence, strategy, industry and performanceSouthern Medical Journal, 6
(1990)
Worldwide Pharmaceutical Industry, Report 901201
Paul Milgrom, John Roberts (1990)
The Economics of Modern Manufacturing: Technology, Strategy, and OrganizationThe American Economic Review, 80
Karel Cool, D. Schendel (1988)
Performance differences among strategic group membersSouthern Medical Journal, 9
E. Roberts, O. Hauptman (1986)
The process of technology transfer to the new biomedical and pharmaceutical firmResearch Policy, 15
J. Barney (1986)
Strategic Factor Markets: Expectations, Luck, and Business StrategyManagement Science, 32
J. Hausman, Bronwyn Hall, Z. Griliches (1984)
Econometric Models for Count Data with an Application to the Patents-R&D RelationshipERN: Econometric Modeling in Microeconomics (Topic)
W. Mitchell (1989)
Whether and When? Probability and Timing of Incumbents' Entry into Emerging Industrial SubfieldsAdministrative Science Quarterly, 34
Nelson Nelson (1991)
Why do firms differ and how does it matter?Strategic Management Journal, 12
(1994)
Measuring organizational knowledge' , Mimeo, Graduate School for Health Studies
(1993)
The effects of human resource management on productivity
S. Lippman, R. Rumelt (1982)
Uncertain Imitability: An Analysis of Interfirm Differences in Efficiency under CompetitionThe Bell Journal of Economics, 13
T. Allen (1977)
Managing the flow of technology: technology transfer and the dissemination of technological informat
Hansen Hansen, Wernerfelt Wernerfelt (1989)
Determinants of firm performance: The relative importance of economic and organizational factorsStrategic Management Journal, 10
Adam Jaffe, Adam Jaffe, Adam Jaffe (1986)
Technological Opportunity and Spillovers of R&D: Evidence from Firms' Patents, Profits and Market ValueThe American Economic Review, 76
D. Westney (1991)
Country patterns in R&D organization : the United States and Japan
H. Grabowski, J. Vernon (1990)
A New Look at the Returns and Risks to Pharmaceutical R&DManagement Science, 36
P. Lawrence, J. Lorsch (1967)
Organization and Environment: Managing Differentiation and Integration
J. Barney (1991)
Firm Resources and Sustained Competitive AdvantageJournal of Management, 17
Cool Cool, Schendel Schendel (1988)
Performance differences among strategic group membersStrategic Management Journal, 9
R. Henderson, I. Cockburn (1996)
Scale, scope, and spillovers: the determinants of research productivity in drug discovery.The Rand journal of economics, 27 1
Robert Burgelman (1994)
Fading Memories: A Process Theory of Strategic Business Exit in Dynamic EnvironmentsAdministrative Science Quarterly, 39
Sheck Sheck, Cox Cox, Davis Davis, Trimble Trimble, Wardell Wardell, Hansen Hansen (1984)
Success rates in the U.S. drug development systemClinical Pharmacology and Therapeutics, 36
A. Shenitzer, J. Steprans (1994)
The evolution of integrationAmerican Mathematical Monthly, 101
T. Roehl, 伊丹 敬之 (1987)
Mobilizing invisible assets
Hitt Hitt, Ireland Ireland (1985)
Corporate distinctive competence, strategy, industry and performanceStrategic Management Journal, 6
Henderson Henderson, Clark Clark (1990)
Architectural innovation: The reconfiguration of existing product technologies and the failure of established firmsAdministrative Science Quarterly, 35
(1991)
Product Development in the World Automobile Industry
R. Rumelt (1991)
How much does industry matterStrategic Management Journal, 12
Renewed interest in the resource‐based theory of the firm has focused attention on the role of heterogeneous organizational ‘competence’ in competition. This paper attempts to measure the importance of these effects in the context of pharmaceutical research. We distinguish between ‘component’ and ‘architectural’ competence, and using internal firm data at the program level from 10 major pharmaceutical companies show that together the two forms of competence appear to explain a significant fraction of the variance in research productivity across firms. Our results raise some intriguing questions about the nature of competencies and the ways in which they diffuse over time.
Strategic Management Journal – Wiley
Published: Dec 1, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.